ASTRAZENECA CAN NOW MARKET DRUG TO TREAT BILLARY TRACT CANCER

New Delhi: The drug firm from India, AstraZeneca, said this Friday it has approval from the Central Drugs Standard Control Organization to market a drug to treat biliary tract cancer in India.

Learn More